Advertisement
Screener

Rein Therapeutics, Inc. (RNTX) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Rein Therapeutics, Inc. Stock-Based Compensation

Rein Therapeutics, Inc. (RNTX) reported Stock-Based Compensation of $320.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-14

  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $164.00K, a 35.94% decline year-over-year.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $156.00K, a 40.91% decline year-over-year.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $257.00K, a 93.23% increase year-over-year.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.45M, a 184.84% increase year-over-year.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.22M, a 99.10% increase from fiscal 2024.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.12M, a 6.13% decline from fiscal 2023.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.19M, a 42.87% decline from fiscal 2022.
  • Rein Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.08M, a 7.83% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$164.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$320.00K
10-Q · filed 2026-08-14
$577.00K
derived: sum of 3 quarters · filed 2026-08-14
$2.02M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$156.00K
10-Q · filed 2026-05-15
$413.00K
derived: sum of 2 quarters · filed 2026-05-15
$1.86M
derived: sum of 3 quarters · filed 2026-05-15
$2.12M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$257.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$1.70M
derived: sum of 2 quarters · filed 2026-03-26
$1.96M
derived: sum of 3 quarters · filed 2026-08-14
$2.22M
10-K · filed 2026-03-26
2025-09-30$1.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$1.70M
derived: sum of 2 quarters · filed 2026-08-14
$1.97M
10-Q · filed 2025-11-14
$2.10M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$256.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$520.00K
10-Q · filed 2026-08-14
$653.00K
derived: sum of 3 quarters · filed 2026-08-14
$1.16M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$264.00K
10-Q · filed 2026-05-15
$397.00K
derived: sum of 2 quarters · filed 2026-05-15
$905.00K
derived: sum of 3 quarters · filed 2026-05-15
$1.23M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$133.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$641.00K
derived: sum of 2 quarters · filed 2026-03-26
$967.00K
derived: sum of 3 quarters · filed 2026-03-26
$1.12M
10-K · filed 2026-03-26
2024-09-30$508.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$834.00K
derived: sum of 2 quarters · filed 2025-11-14
$984.00K
10-Q · filed 2025-11-14
$1.25M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$326.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$476.00K
10-Q · filed 2025-08-14
$746.00K
derived: sum of 3 quarters · filed 2025-08-14
$975.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$150.00K
10-Q · filed 2025-05-15
$420.00K
derived: sum of 2 quarters · filed 2025-05-15
$649.00K
derived: sum of 3 quarters · filed 2025-05-15
$949.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$270.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07
$499.00K
derived: sum of 2 quarters · filed 2025-04-07
$799.00K
derived: sum of 3 quarters · filed 2025-04-07
$1.19M
10-K · filed 2025-04-07
2023-09-30$229.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$529.00K
derived: sum of 2 quarters · filed 2024-11-14
$920.00K
10-Q · filed 2024-11-14
$1.34M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$300.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$691.00K
10-Q · filed 2024-08-14
$1.11M
derived: sum of 3 quarters · filed 2024-08-14
$1.56M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$391.00K
10-Q · filed 2024-05-15
$815.00K
derived: sum of 2 quarters · filed 2024-05-15
$1.26M
derived: sum of 3 quarters · filed 2024-05-15
$1.78M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$424.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
$866.00K
derived: sum of 2 quarters · filed 2024-04-15
$1.39M
derived: sum of 3 quarters · filed 2024-04-15
$2.08M
10-K · filed 2024-04-15
2022-09-30$442.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13
$970.00K
derived: sum of 2 quarters · filed 2023-10-13
$1.66M
10-Q · filed 2023-10-13
$2.27M
derived: sum of 4 quarters · filed 2023-10-13
2022-06-30$528.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$1.22M
10-Q · filed 2023-08-11
$1.82M
derived: sum of 3 quarters · filed 2023-08-11
$2.48M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$689.00K
10-Q · filed 2023-05-08
$1.30M
derived: sum of 2 quarters · filed 2023-05-08
$1.96M
derived: sum of 3 quarters · filed 2023-05-08
$2.32M
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$607.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
$1.27M
derived: sum of 2 quarters · filed 2023-03-20
$1.63M
derived: sum of 3 quarters · filed 2023-03-20
$2.26M
10-K · filed 2023-03-20
2021-09-30$660.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$1.02M
derived: sum of 2 quarters · filed 2022-11-01
$1.65M
10-Q · filed 2022-11-01
$2.02M
derived: sum of 4 quarters · filed 2022-11-01
2021-06-30$362.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
$993.00K
10-Q · filed 2022-08-15
$1.36M
derived: sum of 3 quarters · filed 2022-08-15
$1.82M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$631.00K
10-Q · filed 2022-05-05
$994.00K
derived: sum of 2 quarters · filed 2022-05-05
$1.46M
derived: sum of 3 quarters · filed 2022-05-05
$2.02M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$363.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$828.00K
derived: sum of 2 quarters · filed 2022-03-28
$1.39M
derived: sum of 3 quarters · filed 2022-03-28
$1.89M
10-K · filed 2022-03-28
2020-09-30$465.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$1.02M
derived: sum of 2 quarters · filed 2021-11-12
$1.53M
10-Q · filed 2021-11-12
$2.01M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$560.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$1.06M
10-Q · filed 2021-08-11
$1.54M
derived: sum of 3 quarters · filed 2021-08-11
$2.16M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$505.00K
10-Q · filed 2021-05-11
$984.00K
derived: sum of 2 quarters · filed 2021-05-11
$1.60M
derived: sum of 3 quarters · filed 2021-05-11
$2.06M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$479.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
$1.09M
derived: sum of 2 quarters · filed 2021-03-24
$1.55M
derived: sum of 3 quarters · filed 2021-03-24
$2.12M
10-K · filed 2021-03-24
2019-09-30$614.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$1.07M
derived: sum of 2 quarters · filed 2020-11-12
$1.64M
10-Q · filed 2020-11-12
$2.23M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$460.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$1.02M
10-Q · filed 2020-08-05
$1.61M
derived: sum of 3 quarters · filed 2020-08-05
$2.20M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$563.00K
10-Q · filed 2020-05-11
$1.15M
derived: sum of 2 quarters · filed 2020-05-11
$1.74M
derived: sum of 3 quarters · filed 2020-05-11
$3.08M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$591.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$1.18M
derived: sum of 2 quarters · filed 2020-03-30
$2.51M
derived: sum of 3 quarters · filed 2020-03-30
$3.28M
10-K · filed 2020-03-30
2018-09-30$588.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$1.92M
derived: sum of 2 quarters · filed 2019-11-07
$2.69M
10-Q · filed 2019-11-07
$3.35M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$1.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$2.10M
10-Q · filed 2019-08-06
$2.77M
derived: sum of 3 quarters · filed 2019-08-06
$3.38M
derived: sum of 4 quarters · filed 2019-08-06
2018-03-31$767.00K
10-Q · filed 2019-05-08
$1.43M
derived: sum of 2 quarters · filed 2019-05-08
$2.05M
derived: sum of 3 quarters · filed 2019-05-08
$2.32M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$665.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$1.28M
derived: sum of 2 quarters · filed 2019-03-29
$1.55M
derived: sum of 3 quarters · filed 2019-03-29
$1.75M
10-K · filed 2019-03-29
2017-09-30$615.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$887.00K
derived: sum of 2 quarters · filed 2018-11-07
$1.08M
10-Q · filed 2018-11-07
$1.25M
derived: sum of 4 quarters · filed 2018-11-07
2017-06-30$272.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$469.00K
10-Q · filed 2018-08-07
$638.00K
derived: sum of 3 quarters · filed 2018-08-07
$827.00K
derived: sum of 4 quarters · filed 2018-08-07
2017-03-31$197.00K
10-Q · filed 2018-05-09
$366.00K
derived: sum of 2 quarters · filed 2018-05-09
$555.00K
derived: sum of 3 quarters · filed 2018-05-09
2016-12-31$169.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$358.00K
derived: sum of 2 quarters · filed 2018-04-02
$688.00K
10-K · filed 2018-04-02
2016-09-30$189.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$519.00K
10-Q · filed 2017-11-09
2016-06-30$330.00K
10-Q · filed 2017-08-10
2015-12-31$626.00K
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58